We have located links that may give you full text access.
The injection-adjustable mammary implant.
Annals of Plastic Surgery 1983 September
A double-lumen mammary implant with a custom-made injection valve has been used for patients requesting augmentation mammaplasty since September 1978. The valve allows the alteration of concentration of intraluminal steroids depending upon the clinical response. When capsular contracture occurs the steroid concentration is increased; if a too large breast pocket develops or tissue atrophy occurs the steroid concentration is reduced. The alteration is carried out by an injection technique. An assessment of the first three years of experience with the implant was based on studies of 311 breasts (158 patients, 5 unilateral) followed for at least twelve months. Of these, 224 breasts (113 patients, 2 unilateral) were first-time augmentations, and temporary episodes of capsular contracture occurred during the first twelve months in 23.7% where there was no maintenance steroid, in 17.6% where 5 mg of Solu-Medrol/40 ml was used as initial maintenance steroid, and in 7.8% where 10 mg of Solu-Medrol/40 ml was used as initial maintenance steroid. This custom implant would facilitate the use of antibiotics or other implant additives which in the future may protect the implant from capsular contracture. A double-lumen mammary implant with a custom-made injection valve has been described under the title "Steroid-adjustable mammary implant" [2]. The advent of intralumenal antibiotics [1] prompted the adoption of a more general title for this article.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app